InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: TRUISM post# 12321

Monday, 10/02/2017 10:17:54 AM

Monday, October 02, 2017 10:17:54 AM

Post# of 16885
Sherlock Holmes might make something of this...


From today's press release: "Additional ProNeura feasibility evaluations are ongoing in the area of chronic pain treatment with a peripherally acting Kappa opioid receptor agonist, and in the treatment of type 2 diabetes with currently approved peptides. "

From the "Pipeline" section of Cara Therapeutics website:

"Cara Therapeutics is developing the first peripherally acting kappa opioid receptor agonist (KORA) called CR845."

http://www.caratherapeutics.com/pipeline-technology/kappa-opioid-receptor-agonists/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News